☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Clinical Trial Collaboration
Merck Signs a Clinical Trial Collaboration with Xilio for Anti-CTLA-4 Monoclonal Antibody Program
May 25, 2021
BMS Signs a Clinical Trial Collaboration with UbiVac to Evaluate the Triplet Therapy for Advanced Triple Negative Breast Cancer
June 10, 2020
Cue Biopharma Signs Clinical Trial Collaboration with Merck to Evaluate CUE-101 + Keytruda (pembrolizumab) as 1L Treatment for HPV...
April 21, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.